NCT05137860 2022-01-18
Efficacy of the Use of Bortezomib for the Treatment of Relapsed Leukemia or Positive MRD
Hospital General de Mexico
Phase 4 Unknown
Hospital General de Mexico
Ankara Children's Health and Diseases Hematology and Oncology Training and Research Hospital